Search
for
Sort by
Research 391–420 of 1000+
- Introductory Chapter: Polycystic Ovarian Disease: The Rainbow Without Color (SPECTRUM)
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- COVID-19 in Africa: an ovarian victory?
- Identification of functional circRNAs regulating ovarian follicle development in goats
- The mechanisms of MicroRNA 21 in premature ovarian insufficiency mice with mesenchymal stem cells transplantation
- 3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- Moxibustion improves ovarian function based on the regulation of the androgen balance
- Role of Annexin A2 isoform 2 on the aggregative growth of dermal papillae cells
- ARTIFICIAL INTELLIGENCE AND THE DIAGNOSTIC INVISIBILITY OF WOMEN’S METABOLIC DISORDERS: A NARRATIVE REVIEW OF SOCIO-TECHNICAL CHALLENGES IN PCOS/PMOS RECOGNITION
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- A review of hyperandrogenism state in polycystic ovarian syndrome
- Progress in research on the effects of Platelet-Rich Plasma (PRP) ovarian injection on early ovarian reserve dysfunction and premature ovarian insufficiency
- Primary High‐Grade Ovarian Sertoli–Leydig Cell Tumor With Bilateral Adnexal Involvement in a Patient Diagnosed With Peutz–Jeghers Syndrome
- Retiform Sertoli-Leydig Cell Ovarian Tumour Presenting with Psammoma Bodies: A Rare Case Report
- Insight into the pathogensis of polycystic ovarian syndrome
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- Comparison of In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycle Outcome in Patients with and without Polycystic Ovary Syndrome: A Modified Poisson Regression Model.
- Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Is polymorphism of the STK11 gene a predictor of response to metformin in polycystic ovarian syndrome?
- METABOLIC, REPRODUCTIVE OUTCOMES AND SIDE EFFECTS AFTER THE ADMINISTRATION OF 100 MG DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH AN ADEQUATE OVARIAN RESERVE
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization